Active Ingredient: Haloperidol
Treatment of moderate to severe manic episodes associated with bipolar I disorder.
For this indication, competent medicine agencies globally authorize below treatments:
Oral
2 - 15 mg
From 1 To 7.5 mg 2 time(s) per day every day
2 to 10 mg/day orally, as a single dose or in 2 divided doses.
Adjustments to the dose may be made every 1 to 3 days.
Doses above 10 mg/day have not demonstrated superior efficacy to lower doses in the majority of patients and may cause an increased incidence of extrapyramidal symptoms. The individual benefit-risk should be assessed when considering doses above 10 mg/day.
The maximum dose is 15 mg/day because safety concerns outweigh the clinical benefits of treatment at higher doses.
The continued use of Haloperidol should be evaluated early in treatment.
Gradual withdrawal of haloperidol is advisable.
If patients miss a dose, it is recommended that they take the next dose as usual, and do not take a double dose.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
